13
Views
8
CrossRef citations to date
0
Altmetric
Original

Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases

&
Pages 650-659 | Received 18 Nov 1998, Accepted 21 Apr 1999, Published online: 07 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Minghua Tao, Jiyuan Li, Xuefeng Wang & Xin Tian. (2021) Malignant syndromes: current advances. Expert Opinion on Drug Safety 20:9, pages 1075-1085.
Read now
Ramadhan Oruch, Ian F Pryme, Bernt A Engelsen & Anders Lund. (2017) Neuroleptic malignant syndrome: an easily overlooked neurologic emergency. Neuropsychiatric Disease and Treatment 13, pages 161-175.
Read now
Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Florence Thibaut & Hans-Jürgen Möller. (2013) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. The World Journal of Biological Psychiatry 14:1, pages 2-44.
Read now
Iannis M. Zervas, Christos Theleritis & Costantin R. Soldatos. (2012) Using ECT in schizophrenia: A review from a clinical perspective. The World Journal of Biological Psychiatry 13:2, pages 96-105.
Read now
Hazem Shoirah & Hesham M Hamoda. (2011) Electroconvulsive therapy in children and adolescents. Expert Review of Neurotherapeutics 11:1, pages 127-137.
Read now
Colleen Loo, Julian Trollor, Angelo Alonzo, Nicola Rendina & Rosemary Kavess. (2010) Mental health legislation and psychiatric treatments in NSW: electroconvulsive therapy and deep brain stimulation. Australasian Psychiatry 18:5, pages 417-425.
Read now
Robert L Rodnitzky. (2005) Drug-induced movement disorders in children and adolescents. Expert Opinion on Drug Safety 4:1, pages 91-102.
Read now
Joseph W. Y. Lee. (2000) Catatonic and non-catatonic neuroleptic malignant syndrome. Australian and New Zealand Journal of Psychiatry 34:5, pages 877-877.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.